1. Home
  2. |Insights
  3. |False Claims Act: Key Provisions and Current Trends in Compliance and Enforcement - L2 Federal Resources Webinar

False Claims Act: Key Provisions and Current Trends in Compliance and Enforcement - L2 Federal Resources Webinar

Event | 06.14.12, 12:00 AM UTC - 12:00 AM UTC

Click here to access the presentation materials [PDF]

The False Claims Act (“FCA”) is the government’s primary enforcement tool for combating fraud in connection with alleged false claims made for federal funds. Since the FCA was amended in 1986, more than $30 billion dollars has been recovered in damages, fines and penalties, impacting a wide array of industries including health care, mortgage financing, and government procurement. In addition to FCA violations being subject to treble damages and penalties of between $5,500 to $11,000 per claim, companies face the risk of suspension and debarment, and in some cases, criminal prosecution. Understanding the liability risks under the FCA and the current trends in enforcement is essential for ensuring compliance and mitigating exposure risks.

This 90-minute webinar will provide an overview of key FCA provisions to help you understand the risks, with practical examples and guidance that will equip you to identify and avoid potential FCA violations. In tandem, it will also cover reporting obligations related to potential violation of the FCA and other statutory provisions under the Mandatory Disclosure Rules of the Federal Acquisition Regulations, and discussion on recent trends in compliance and enforcement.

For more information, please visit these areas: Government Contracts

Insights

Event | 12.04.25

ACI 30th Annual Conference on Drug & Medical Device Litigation

Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures.